Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Middle-Aged and Older Chinese People

Journal of the American College of Cardiology

Volumn 49, Issue 17, 2007, Pages 1798-1805

  Ye, Xingwang ^a   Yu, Zhijie ^a   Li, Huaixing ^a   Franco, Oscar H ^b   Liu, Yong ^a   Lin, Xu ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; CHINESE; CONTROLLED STUDY; EDUCATION PROGRAM; FAMILY HISTORY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RURAL AREA; URBAN AREA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RURAL HEALTH; SOCIOECONOMIC FACTORS; URBAN HEALTH;

EID: 34247330154     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.065     Document Type: Article

References (33)

1. Gu D., Reynolds K., Wu X., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
2. Liu J., Grundy S.M., Wang W., et al. Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care 29 (2006) 1414-1416
3. Tataranni P.A., and Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?. Diabetes 54 (2005) 917-927
4. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
5. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
6. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W.F. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
7. Nakanishi S., Yamane K., Kamei N., Okubo M., and Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26 (2003) 2754-2757
8. Hu F.B., Meigs J.B., Li T.Y., Rifai N., and Manson J.E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53 (2004) 693-700
9. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., and Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25 (2002) 2016-2021
10. Laaksonen D.E., Niskanen L., Nyyssonen K., et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47 (2004) 1403-1410
11. Albert M.A., Glynn R.J., Buring J., and Ridker P.M. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
12. Anand S.S., Razak F., Yi Q., et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 24 (2004) 1509-1515
13. Matthews K.A., Sowers M.F., Derby C.A., et al. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J 149 (2005) 1066-1073
14. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
15. Yamada S., Gotoh T., Nakashima Y., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 153 (2001) 1183-1190
16. Ford E.S., Giles W.H., Mokdad A.H., and Myers G.L. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem 50 (2004) 574-581
17. Ledue T.B., and Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 49 (2003) 1258-1271
18. Nakanishi N., Shiraishi T., and Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study. Circ J 69 (2005) 386-391
19. Bo S., Gentile L., Ciccone G., et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 21 (2005) 515-524
20. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). Available at: http://www.ipaq.ki.se/dloads/IPAQ%20LS%20Scoring%20Protocols_Nov05.pdf. Accessed July 01, 2006.
21. Bei-Fan Z., and Cooperative Meta-Analysis Group of Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 11 (2002) S685-S693
22. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) e285-e290
23. Yen M.L., Yang C.Y., Yen B.L., Ho Y.L., Cheng W.C., and Bai C.H. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol 110 (2006) 191-198
24. Shiesh S.C., Chou T.C., Lin X.Z., and Kao P.C. Determination of C-reactive protein with an ultra-sensitivity immunochemiluminometric assay. J Immunol Methods 311 (2006) 87-95
25. MacGregor A.J., Gallimore J.R., Spector T.D., and Pepys M.B. Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins. Clin Chem 50 (2004) 130-134
26. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
27. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
28. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23 (2000) 1835-1839
29. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
30. Lee W.Y., Park J.S., Noh S.Y., et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol 97 (2004) 101-106
31. Wannamethee S.G., Lowe G.D., Shaper A.G., Rumley A., Lennon L., and Whincup P.H. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 181 (2005) 101-108
32. He Y., Jiang B., Wang J., et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 47 (2006) 1588-1594
33. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511